Persistent Markers of Infection Tied to Higher Likelihood of Long COVID Symptoms
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 10, 2024 -- The presence of persistent antigen is associated with having postacute sequelae of COVID-19 (PASC) symptoms, according to a study published online Oct. 8 in Clinical Microbiology and Infection.
Zoe Swank, Ph.D., from Brigham and Women's Hospital in Boston, and colleagues assessed the proportion of individuals with detectable antigen in plasma or serum after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the association between antigen detection with PASC symptoms. The analysis included 1,569 samples from 706 individuals infected with SARS-CoV-2.
The researchers found that 21 percent of samples were positive for either S1, spike, or nucleocapsid, with spike predominantly detected. The highest proportion of spike-positive samples (20 percent) was seen between four and seven months postinfection. At more than one month postinfection, 82 percent of participants reported at least one of the 34 PASC symptoms examined. The highest prevalence of PASC symptoms was seen for cardiopulmonary, musculoskeletal, and neurologic symptoms, which were reported in more than half of all participants. Among these participants, 43 percent were antigen-positive, on average. Eighteen percent of participants reported no ongoing symptoms and antigen was detected in 21 percent of them. When adjusting for sex, age, time postinfection, and cohort, the presence of antigen was associated with the presence of one or more PASC symptoms (odds ratio, 1.8).
"The findings of this multicohort study indicate that SARS-CoV-2 antigens can be detected in the blood of a substantial proportion of individuals up to 14 months after infection," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted October 2024
Further Support and Information on COVID-19
Read this next
Widespread Decline Seen in MMR Vaccination Rates After COVID-19
THURSDAY, June 5, 2025 -- A widespread decrease in measles-mumps-rubella (MMR) vaccination rates was seen after the COVID-19 pandemic, according to a research letter published...
Maternal Obesity Linked to Pediatric Hospital Admissions for Infection
WEDNESDAY, June 4, 2025 -- Maternal obesity grades 2 and 3 is associated with hospital admissions for infection throughout childhood, according to a study published online June 3...
Psoriasis Tied to Increased Risk for Sleep Disorders
MONDAY, June 2, 2025 -- Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.